Pharmacotherapy for Child and Adolescent Attention-deficit Hyperactivity Disorder

Gabriel Kaplan, Jeffrey H. Newcorn

Research output: Contribution to journalReview articlepeer-review

60 Scopus citations


Research in the past 2 decades showed that attention-deficit/hyperactivity disorder (ADHD) is a frequently occurring psychiatric disorder that causes considerable suffering to patients and their families. This article outlines current pharmacologic ADHD treatment options and focuses on their safety profile and efficacy. In addition, it addresses treatment selection, guidelines for monitoring treatment, and recent controversies in the field.

Original languageEnglish
Pages (from-to)99-120
Number of pages22
JournalPediatric Clinics of North America
Issue number1
StatePublished - Feb 2011


  • ADHD
  • Atomoxetine
  • Guanfacine
  • Pharmacotherapy
  • Stimulants


Dive into the research topics of 'Pharmacotherapy for Child and Adolescent Attention-deficit Hyperactivity Disorder'. Together they form a unique fingerprint.

Cite this